Latest News
21 August 2014 Abzena’s subsidiary Antitope and University College London enter into a Research & Licence Agreement for the generation of fully humanized antibodies using Antitope’s Composite Human Antibody™ technology Read More
Upcoming Events
22 - 24 September 2014 BioPharm America 2014
Boston, MA, USA
2 October 2014 The EPIC Biotech Conference
London, UK
20 - 22 October 2014 IIR 15th Annual Immunogenicity for Biotherapeutics
Boston, MA, USA
Abzena offers a suite of complementary services and technologies through its subsidiaries, PolyTherics and Antitope, to enable the development of better biopharmaceuticals which will have a greater chance of reaching the market.
Privacy & cookie policy
© Abzena plc, 2014. All rights reserved.